Showing results (331-340 of 1,165) with videos related to

Sort By:
Pageof 117
Epidemiology and Infection|April 1, 1988
Epidemic cholera in Mali: high mortality and multiple routes of transmission in a famine areaR V Tauxe, S D Holmberg, A Dodin, et al.
European Journal of Immunology|October 3, 1999
Altered VH6-D-JH repertoire in human insulin-dependent diabetes mellitus and autoimmune idiopathic thrombocytopenic purpuraI Söderström, I van Dijk-Härd, S Feld, et al.
European Journal of Immunology|November 9, 2000
The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte developmentI Bergqvist, M Eriksson, J Saarikettu, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?J R Graybill, L K Najvar, J D Holmberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2013
Causes of death and characteristics of decedents with viral hepatitis, United States, 2010Kathleen N Ly, Jian Xing, R Monina Klevens, et al.
AIDS (London, England)|December 4, 2004
Factors associated with chronic renal failure in HIV-infected ambulatory patientsChristopher S Krawczyk, Scott D Holmberg, Anne C Moorman, et al.
Hepatology (Baltimore, Md.)|July 15, 2015
Toward a more accurate estimate of the prevalence of hepatitis C in the United StatesBrian R Edlin, Benjamin J Eckhardt, Marla A Shu, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|July 17, 1992
Testing for antibodies to human immunodeficiency virus type 2 in the United StatesT R O'Brien, J R George, J S Epstein, et al.
The Journal of Infectious Diseases|February 10, 1999
Combination antiretroviral therapy and recent declines in AIDS incidence and mortalityE Vittinghoff, S Scheer, P O'Malley, et al.
American Journal of Public Health|April 1, 1992
HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in AmsterdamC Hartgers, A van den Hoek, P Krijnen, et al.
Pageof 117